Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Drew W. Rasco
Anti-Tumor Activity of PEGylated Human IL-10 (AM0010) in Patients With Pancreatic or Colorectal Cancer.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase I Study of CC-486 Alone and in Combination With Carboplatin or Nab‑paclitaxel in Patients With Relapsed or Refractory Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Clinical Activity and Safety of Pegylated Human IL-10 (AM0010) in Combination With Anti-Pd1.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prognostic Significance of Isolated Tumor Cells in Patients With Colorectal Cancer in Recent 10-Year Studies
Molecular and Clinical Oncology
Cancer Research
Oncology
2363 Inducing Anti-Tumor Immunity in Colorectal Cancer
Journal of Clinical and Translational Science
Medicine
IL-35 Hinders Endogenous Anti-Tumor T Cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer
Cancer immunology research
Cancer Research
Immunology
Correlation Analysis of IL‑4, IL‑10 and APN Levels With Postoperative Infection of Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Decreased Indoleamine 2,3-Dioxygenase Activity and IL-10/IL-17A Ratio in Patients With COPD
Thorax
Pulmonary
Respiratory Medicine
Paradoxical Role of HMGB1 in Pancreatic Cancer: Tumor Suppressor or Tumor Promoter?
Anticancer Research
Medicine
Cancer Research
Oncology
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
Cancer Cell
Cancer Research
Oncology
Cell Biology
Anti-Tumor Activity of New Quinoline Derivatives in Human Breast Cancer T47D Cells
International Journal of Cancer Research
Cancer Research
Oncology